Li, Qi <br/><br/>
20(S)-Ginsenoside Rh2 suppresses proliferation and migration of hepatocellular carcinoma cells by targeting EZH2 to regulate CDKN2A-2B gene cluster transcription.  [electronic resource] 

 -  European journal of pharmacology  Nov 2017 
 - 173-180 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1879-0712 
<br/><br/><label>Standard No.: </label>10.1016/j.ejphar.2017.09.023  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Carcinoma, Hepatocellular--drug therapy<br/>Cell Line, Tumor<br/>Cell Movement--drug effects<br/>Cell Proliferation--drug effects<br/>Cyclin-Dependent Kinase Inhibitor p15--genetics<br/>Cyclin-Dependent Kinase Inhibitor p16--genetics<br/>Down-Regulation--drug effects<br/>Enhancer of Zeste Homolog 2 Protein--metabolism<br/>G1 Phase Cell Cycle Checkpoints--drug effects<br/>Ginsenosides--pharmacology<br/>Humans<br/>Liver Neoplasms--drug therapy<br/>Male<br/>Mice<br/>Molecular Targeted Therapy<br/>Multigene Family--genetics<br/>Promoter Regions, Genetic--genetics<br/>RNA, Messenger--genetics<br/>Resting Phase, Cell Cycle--drug effects<br/>Transcription, Genetic--drug effects<br/>Xenograft Model Antitumor Assays